(Australia-NewsWire.Com, November 30, 2017 ) According to the report Cell Based Assay Market, published by Market Data Forecast, the Asia Pacific market was worth USD 2.01 billion in 2017 and estimated to be growing at a CAGR of 12.6%, to reach USD 3.63 billion by 2022.
Cell based assay market is a technique used to test living cells based on various parameters to determine the virtual functions of biochemical or cellular processes. Functional cells work as analytical instruments in the research for new innovative drugs in cell based assays. Furthermore, they Cell ease the research in the fields of stem cells, cancer, immunology, and others.
Cell Based Assay Market: Drivers & Restraints Factors such as technological advancement, increasing R&D activities in drug discovery and increasing government expenditure coupled with rise in demand of biological drugs, and growing requirement for toxicity screening before prescription of certain drugs is expected to drive the market growth. Moreover, recent discovery developing technologically enhanced products, advantages associated with cell based assay, and the growing need to reduce the expenditure associated with drug innovations are expected to further fuel the global market for cell based assays. However, rigid property rights, lack of skilled personnel, and expensive nature of instruments are key restricting the growth of the market.
Cell Based Assay Market: Overview Asia Pacific is projected to show highest growth rate in the cell based assays market in coming few years.
Cell Based Assay Market: Key Players Some of the key companies dominating the global Cell Based Assay market are General Electric Company, Cisbio Bioassays, PerkinElmer Inc., DiscoveRx, Ametek Inc., Promega Corporation, Bio-Rad Laboratories, Danaher Corporation, Roche Diagnostics, GE Healthcare, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.